Premier Asset Management LLC Johnson & Johnson Transaction History

Premier Asset Management LLC

$0
Q1 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $78,337 - $87,917	-489 Reduced 9.8%	4,499 $794,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $273,131 - $303,927	-1,693 Reduced 25.34%	4,988 $815,000
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $531,816 - $588,163	-3,162 Reduced 32.12%	6,681 $1.17 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $854,746 - $970,683	-5,405 Reduced 35.45%	9,843 $1.74 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $392,008 - $434,947	-2,514 Reduced 14.15%	15,248 $2.61 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $782,629 - $869,711	4,846 Added 37.52%	17,762 $2.87 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $232,202 - $249,077	1,456 Added 12.71%	12,916 $2.13 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $549,827 - $612,364	3,592 Added 45.65%	11,460 $1.88 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $501,548 - $575,696	3,658 Added 86.89%	7,868 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $590,999 - $647,624	4,210 New	4,210 $627,000
Q4 2019 Jan 23, 2020	SELL	$127.5 - $146.44 $554,497 - $636,867	-4,349 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$126.95 - $142.14 $31,610 - $35,392	249 Added 6.07%	4,349 $563,000
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $19,934 - $21,924	152 Added 3.85%	4,100 $571,000
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $130,371 - $144,962	1,037 Added 35.62%	3,948 $551,000
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $18,237 - $21,432	150 Added 5.43%	2,911 $402,000
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $1,432 - $1,581	12 Added 0.44%	2,761 $335,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $355,913 - $372,159	2,749	2,749 $357,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Account